Literature DB >> 28176151

Frequent BRAF V600E and Absence of TERT Promoter Mutations Characterize Sporadic Pediatric Papillary Thyroid Carcinomas in Japan.

Naoki Oishi1, Tetsuo Kondo1, Tadao Nakazawa1, Kunio Mochizuki1, Tomohiro Inoue1, Kazunari Kasai1, Ippei Tahara1, Tomonori Yabuta2, Mitsuyoshi Hirokawa3, Akira Miyauchi2, Ryohei Katoh4.   

Abstract

Pediatric papillary thyroid carcinoma (PTC) has unique features but requires further genetic investigation. Moreover, there has been increasing concern about the risk for pediatric PTC in Japan after the Fukushima accident. This study aims to evaluate the frequencies of BRAF and TERT promoter mutations and to examine their significance in non-radiation-associated pediatric PTCs in Japan. We enrolled 81 pediatric PTC patients aged ≤20 years. The control group included 91 adult PTCs from patients >20 years old. BRAF and TERT mutations were analyzed by allele-specific-PCR and/or Sanger sequencing. Compared with adult PTCs, pediatric PTCs exhibited larger tumor size, more frequent lymph node metastasis, and less classical histology. The prevalence of BRAF V600E in pediatric PTCs was 54% and significantly lower than that in adults of 85%. In the pediatric PTCs, BRAF V600E was positively associated with older age, classical histology, and the lymph node metastasis but independent from other clinicopathological factors. TERT mutations were identified in 13% of adults and in none of the pediatric PTCs. In conclusion, pediatric PTCs are characterized by more advanced clinicopathological features, lower BRAF V600E frequency, and absence of TERT mutation. The BRAF V600E frequency in this study is similar to the reported BRAF V600E frequency in the ultrasonographically screened pediatric PTCs in Fukushima.

Entities:  

Keywords:  Adult; BRAF; Mutation; Papillary thyroid carcinoma; Pediatric; TERT

Mesh:

Substances:

Year:  2017        PMID: 28176151     DOI: 10.1007/s12022-017-9470-y

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  44 in total

1.  Differentiated thyroid cancer in children and adolescents.

Authors:  D Giuffrida; C Scollo; G Pellegriti; G Lavenia; M P Iurato; V Pezzin; A Belfiore
Journal:  J Endocrinol Invest       Date:  2002-01       Impact factor: 4.256

Review 2.  Papillary thyroid carcinoma: an update.

Authors:  Virginia A LiVolsi
Journal:  Mod Pathol       Date:  2011-04       Impact factor: 7.842

3.  Papillary thyroid carcinomas with and without BRAF V600E mutations are morphologically distinct.

Authors:  Alexander Finkelstein; Gillian H Levy; Pei Hui; Avinash Prasad; Renu Virk; David C Chhieng; Tobias Carling; Sanziana A Roman; Julie A Sosa; Robert Udelsman; Constantine G Theoharis; Manju L Prasad
Journal:  Histopathology       Date:  2012-02-15       Impact factor: 5.087

4.  Integrated genomic characterization of papillary thyroid carcinoma.

Authors: 
Journal:  Cell       Date:  2014-10-23       Impact factor: 41.582

Review 5.  Diffuse sclerosing variant of papillary thyroid carcinoma--an update of its clinicopathological features and molecular biology.

Authors:  Suja Pillai; Vinod Gopalan; Robert A Smith; Alfred K-Y Lam
Journal:  Crit Rev Oncol Hematol       Date:  2014-12-18       Impact factor: 6.312

6.  Does BRAF V600E mutation predict aggressive features in papillary thyroid cancer? Results from four endocrine surgery centers.

Authors:  Carol Li; Patricia Aragon Han; Kathleen C Lee; Louis C Lee; Amy C Fox; Toni Beninato; Michele Thiess; Benzon M Dy; Thomas J Sebo; Geoffrey B Thompson; Clive S Grant; Thomas J Giordano; Paul G Gauger; Gerard M Doherty; Thomas J Fahey; Justin Bishop; James R Eshleman; Christopher B Umbricht; Eric B Schneider; Martha A Zeiger
Journal:  J Clin Endocrinol Metab       Date:  2013-08-22       Impact factor: 5.958

7.  The age- and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomas.

Authors:  T Liu; N Wang; J Cao; A Sofiadis; A Dinets; J Zedenius; C Larsson; D Xu
Journal:  Oncogene       Date:  2013-10-21       Impact factor: 9.867

8.  Lack of association of BRAF mutation with negative prognostic indicators in papillary thyroid carcinoma: the University of California, San Francisco, experience.

Authors:  Christopher Gouveia; Nhu Thuy Can; Alan Bostrom; James P Grenert; Annemieke van Zante; Lisa A Orloff
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2013-11       Impact factor: 6.223

9.  Childhood thyroid cancer in England and Wales.

Authors:  H R Harach; E D Williams
Journal:  Br J Cancer       Date:  1995-09       Impact factor: 7.640

10.  BRAF(V600E) mutation is highly prevalent in thyroid carcinomas in the young population in Fukushima: a different oncogenic profile from Chernobyl.

Authors:  Norisato Mitsutake; Toshihiko Fukushima; Michiko Matsuse; Tatiana Rogounovitch; Vladimir Saenko; Shinya Uchino; Masahiro Ito; Keiji Suzuki; Shinichi Suzuki; Shunichi Yamashita
Journal:  Sci Rep       Date:  2015-11-20       Impact factor: 4.379

View more
  11 in total

1.  Molecular alterations of coexisting thyroid papillary carcinoma and anaplastic carcinoma: identification of TERT mutation as an independent risk factor for transformation.

Authors:  Naoki Oishi; Tetsuo Kondo; Aya Ebina; Yukiko Sato; Junko Akaishi; Rumi Hino; Noriko Yamamoto; Kunio Mochizuki; Tadao Nakazawa; Hiroshi Yokomichi; Koichi Ito; Yuichi Ishikawa; Ryohei Katoh
Journal:  Mod Pathol       Date:  2017-07-21       Impact factor: 7.842

2.  Molecular pathogenesis of pediatric thyroid carcinoma.

Authors:  Norisato Mitsutake; Vladimir Saenko
Journal:  J Radiat Res       Date:  2021-05-05       Impact factor: 2.724

Review 3.  Radiation and Thyroid Cancer.

Authors:  Elisabetta Albi; Samuela Cataldi; Andrea Lazzarini; Michela Codini; Tommaso Beccari; Francesco Saverio Ambesi-Impiombato; Francesco Curcio
Journal:  Int J Mol Sci       Date:  2017-04-26       Impact factor: 5.923

4.  Somatic genetic alterations in a large cohort of pediatric thyroid nodules.

Authors:  Barbora Pekova; Sarka Dvorakova; Vlasta Sykorova; Gabriela Vacinova; Eliska Vaclavikova; Jitka Moravcova; Rami Katra; Petr Vlcek; Pavla Sykorova; Daniela Kodetova; Josef Vcelak; Bela Bendlova
Journal:  Endocr Connect       Date:  2019-06       Impact factor: 3.335

5.  Incidence of BRAF V600E mutation in patients with papillary thyroid carcinoma: a single-institution experience.

Authors:  Shoko Kure; Kousuke Ishino; Mitsuhiro Kudo; Ryuichi Wada; Marie Saito; Ryuta Nagaoka; Iwao Sugitani; Zenya Naito
Journal:  J Int Med Res       Date:  2019-09-18       Impact factor: 1.671

6.  The BRAFV600E Mutation Is Not a Risk Factor for More Aggressive Tumor Behavior in Radiogenic and Sporadic Papillary Thyroid Carcinoma at a Young Age.

Authors:  Liudmyla Zurnadzhy; Tetiana Bogdanova; Tatiana I Rogounovitch; Masahiro Ito; Mykola Tronko; Shunichi Yamashita; Norisato Mitsutake; Serhii Chernyshov; Sergii Masiuk; Vladimir A Saenko
Journal:  Cancers (Basel)       Date:  2021-11-30       Impact factor: 6.639

7.  The clinical significance of BRAFV600E mutations in pediatric papillary thyroid carcinomas.

Authors:  Yangsen Li; Yuanyuan Wang; Liwen Li; Xinguang Qiu
Journal:  Sci Rep       Date:  2022-07-25       Impact factor: 4.996

Review 8.  Thyroid Cancer in the Pediatric Population.

Authors:  Vera A Paulson; Erin R Rudzinski; Douglas S Hawkins
Journal:  Genes (Basel)       Date:  2019-09-18       Impact factor: 4.096

9.  Association between TERT promoter mutations and clinical behaviors in differentiated thyroid carcinoma: a systematic review and meta-analysis.

Authors:  Jing Yang; Yanping Gong; Shuping Yan; Hui Chen; Siqin Qin; Rixiang Gong
Journal:  Endocrine       Date:  2019-10-26       Impact factor: 3.633

Review 10.  Telomere Maintenance in Pediatric Cancer.

Authors:  Sandra Ackermann; Matthias Fischer
Journal:  Int J Mol Sci       Date:  2019-11-20       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.